Senti Biosciences Inc.
SNTI
Get informed when a big investor buys or sells
+ FollowMarket Cap$11.74M
Close$
$-0.06
116.3% downside
Current Fair Value
116.3% downsideOvervalued by 116.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $11.74 Million |
|---|---|
| Enterprise Value | $27.44 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.73 |
| Beta | 2.11 |
| Outstanding Shares | 31,144,754 |
Return
| Return on Equity | 1457.34% |
|---|---|
| Return on Assets | -149.72% |
| Return on Invested Capital | -317.36% |
Valuation & Multiples
| P/E Ratio | -0.21 |
|---|---|
| PEG | 1.58 |
| Price to Sales | - |
| Price to Book Ratio | -0.34 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -0.5 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.81 |
| Debt to Equity | -6.52 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 18, 2026
EPS Estimate
$-0.28
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
November 12, 2026
EPS Estimate
$-0.21
Average shareholder expectationRevenue Estimate
$15,867
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.97%0% |
|---|---|
| Total Invested | $357,795▼ 33.18% |
| Investors Holding | 10% |
ESG Score
No data
About Senti Biosciences Inc.
4 employees